Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
P1.09 - Poster Session 1 - Combined Modality
- Type: Poster Session
- Track: Combined Modality
- Presentations: 22
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.09-009 - Preliminary Safety and Treatment Delivery Data During Concurrent Phase of Chemoradiation Therapy of the PROCLAIM Trial: A Phase 3 Trial of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Stage III Nonsquamous Cell Lung Cancer.
09:30 - 09:30 | Author(s): E. Vokes
- Abstract
Loading... -
+
P1.09-022 - A Multicenter, Randomized, Open-label, Phase II Trial of Erlotinibversus Etoposideplus Cisplatinwith Concurrent Radiotherapy in UnresectableStage III Non-smallCell Lung Cancer (NSCLC) with Activating Mutation of Epidermal Growth Factor Receptor (EGFR) in Exon 19 or 21(RECEL, ML28545, NCT01714908)
09:30 - 09:30 | Author(s): L. Xing
- Abstract
Loading...
-
+
P1.11 - Poster Session 1 - NSCLC Novel Therapies
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 45
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.11-038 - The significance of ALK rearrangement in selected advanced non-small cell lung cancer: ALK expression provides insights into ALK target therapy
09:30 - 09:30 | Author(s): N. Zhang
- Abstract
Loading...
-
+
P1.15 - Poster Session 1 - Thymoma
- Type: Poster Session
- Track: Thymoma & Other Thoracic Malignancies
- Presentations: 9
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.15-002 - Results and Prognostic Features of Recurrent Thymoma
09:30 - 09:30 | Author(s): C. Xu
- Abstract
Loading...
-
+
MO01 - Lung Cancer Biology - Techniques and Platforms
- Type: Mini Oral Abstract Session
- Track: Biology
- Presentations: 10
- Moderators:S. Lu
- Coordinates: 10/28/2013, 10:30 - 12:00, Bayside 204 A+B, Level 2
-
+
MO01.07 - Inhibition of the IGF-1R signaling pathway potentiates responses to ALK inhibitors in both ALK TKI naive and ALK TKI resistant lung cancer
11:00 - 11:05 | Author(s): C.M. Lovly
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
O01 - Prognostic and Predictive Biomarkers I
- Type: Oral Abstract Session
- Track: Medical Oncology
- Presentations: 8
- Moderators:T. Mitsudomi
- Coordinates: 10/28/2013, 10:30 - 12:00, Parkside Auditorium, Level 1
-
+
O01.02 - MicroRNA Signature Predicts Survival in Resectable Small-Cell Lung Cancer
10:40 - 10:50 | Author(s): N. Bi
- Abstract
Loading...
-
+
MO05 - Prognostic and Predictive Biomarkers II
- Type: Mini Oral Abstract Session
- Track: Medical Oncology
- Presentations: 12
- Moderators:J. Hu
- Coordinates: 10/28/2013, 16:15 - 17:45, Parkside Auditorium, Level 1
-
+
MO05.01 - Validation of gene expression biomarker panels in non-small cell lung cancer
16:15 - 16:20 | Author(s): J. Dong
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.02 - Poster Session 2 - Novel Cancer Genes and Pathways
- Type: Poster Session
- Track: Biology
- Presentations: 21
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.02-003 - DNA methylation and expression patterns in adenocarcinomas of the lung of never-smokers with discordant methylation and expression patterns of homeobox related genes
10:04 - 10:21 | Author(s): A.S. Mansfield
- Abstract
Loading...
-
+
P2.10 - Poster Session 2 - Chemotherapy
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 52
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.10-031 - Chinese randomized phase II trial of customized chemotherapy based on BRCA1-RAP80 mRNA expression in advanced non-small-cell lung cancer (NSCLC) patients (p) (ChiCTR-TRC-12001860/BREC-CHINA)
09:30 - 09:30 | Author(s): J. Wei
- Abstract
Loading...
-
+
P2.11 - Poster Session 2 - NSCLC Novel Therapies
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 46
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.11-026 - RET Fusion-Positive Advanced Lung Cancers: Response to First-Line Chemotherapy and Survival in Comparison to ROS1 and ALK Fusion-Positive and EGFR- and KRAS-Mutant Lung Cancers
09:30 - 09:30 | Author(s): A. Drilon
- Abstract
Loading... -
+
P2.11-043 - Analysis of clinicopathological features for Chinese patients with advanced non-small cell lung cancer harboring EML4-ALK fusion genes
09:30 - 09:30 | Author(s): Y. Shi
- Abstract
Loading...
-
+
P2.15 - Poster Session 2 - Thymoma
- Type: Poster Session
- Track: Thymoma & Other Thoracic Malignancies
- Presentations: 8
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
